Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06809907Recruiting

Kintsugi Voice Device Pivotal Study

Role: lead

NCT06374056Active Not Recruiting

Kintsugi Voice Device Pilot Study

Role: lead

NCT05554042Completed

Kintsugi Voice Device Study

Role: lead

NCT04510519Completed

Scaling Mental Healthcare in COVID-19 With Voice Biomarkers

Role: lead

NCT05455905Completed

Voice Biomarkers Predictive of Depression and Anxiety

Role: lead

NCT04874077Completed

Using Voice Biomarkers to Predict the Likelihood of Major Depressive Disorder

Role: lead

All 6 trials loaded